Aggressive Digital Papillary Adenocarcinoma (DPA) is a rare type of skin cancer that originates from sweat glands, primarily affecting the fingers and toes. This tumor is known for its potential ...

The Bachelorette’s Ali Fedotowsky and her husband Kevin Manno opened up about his recent thyroid cancer diagnosis on social media, sharing that they are optimistic about his road to recovery.

They include familial medullary thyroid carcinoma (RET gene), familial adenomatous polyposis (APC gene), Cowden ... Sometimes a nodule is examined with imaging and/or biopsy to determine whether it ...

Bladder cancer can be curable, and the likelihood of cure is higher if it is diagnosed at an early stage. Without treatment, bladder cancer does not go away on its own, and treatment is associated ...

Lung adenocarcinoma (LUAD) is a common type of lung cancer that arises from glandular cells in the lungs. Understanding the prognosis and classification of LUAD is crucial for determining ...

The differential diagnosis of malignant melanoma includes atypical nevi, dermatofibromas, lentigos, basal cell carcinoma (especially pigmented types), squamous cell carcinoma, keloids, and ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

ImmunityBio has a promising cancer treatment, Anktiva. We warn of financial risks and lack of transparency for retail investors. See more on IBRX stock here.

with carcinoma in situ (CIS), with or without papillary tumors, to both the European Union (EU) European Medicines Agency (EMA) and the United King CULVER CITY, Calif., January 15, 2025 ...

“In this phase 2 study, an image-guided adaptive strategy enabled radiotherapy dose escalation to over 86% of patients’ bladder tumors without significant increase in toxicity,” wrote the authors.

Overall, 39% of those who received a university-formatted report and 56% of those who received a VA-formatted report were able to identify that they had prostate cancer.

2025 is set to be a game-changing year for cancer research, with cutting-edge therapies and technologies driving unprecedented progress in oncology.